Arcadia Biosciences's market cap is currently $6.99M. The company's EPS TTM is $-4.402; its P/E ratio is ―; Arcadia Biosciences is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-0.89. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 5.33M	$ 9.96M	$ 6.78M	$ 8.03M	$ 1.17M
Gross Profit	$ 2.03M	$ 154.00K	$ -1.93M	$ 2.83M	$ 284.00K
Operating Income	$ -13.94M	$ -19.40M	$ -35.53M	$ -21.59M	$ -20.38M
EBITDA	$ -13.58M	$ -13.65M	$ -23.27M	$ -5.44M	$ -28.67M
Net Income	$ -13.98M	$ -15.61M	$ -16.13M	$ -6.03M	$ -28.87M
Balance Sheet
Cash & Short-Term Investments	$ 11.64M	$ 20.64M	$ 28.68M	$ 25.67M	$ 25.33M
Total Assets	$ 19.70M	$ 28.92M	$ 43.92M	$ 47.35M	$ 32.57M
Total Debt	$ 1.01M	$ 2.02M	$ 3.29M	$ 9.35M	$ 2.24M
Net Debt	$ -5.51M	$ -18.63M	$ -25.39M	$ -4.69M	$ -6.18M
Total Liabilities	$ 7.00M	$ 8.02M	$ 12.72M	$ 18.80M	$ 24.25M
Stockholders' Equity	$ 12.84M	$ 21.03M	$ 31.09M	$ 27.73M	$ 7.71M
Cash Flow
Free Cash Flow	$ -15.30M	$ -14.05M	$ -26.88M	$ -32.55M	$ -18.68M
Operating Cash Flow	$ -15.29M	$ -13.98M	$ -25.87M	$ -30.22M	$ -17.20M
Investing Cash Flow	$ -4.34M	$ 1.42M	$ 16.61M	$ 17.28M	$ -8.37M
Financing Cash Flow	$ 5.51M	$ 4.52M	$ 21.90M	$ 20.56M	$ 21.99M

Currency in USD

Arcadia Biosciences Earnings and Revenue History

Income Statement >

Arcadia Biosciences Debt to Assets

Balance Sheet >

Arcadia Biosciences Cash Flow

Cash Flow >

Arcadia Biosciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing